Union of Giants: Thermo Fisher Acquires Life Technologies

Related Vendors

EagleBurgmann Germany GmbH & Co. KG

Glatt Ingenieurtechnik GmbH

Maag Pump Systems AG

This multi–billion–dollar mega–deal could create huge possibilities for Thermo Fisher customers working in research, specialty diagnostics and applied markets, the company believes:

• It strengthens technology and innovation leadership through complementary offerings that broaden Thermo Fisher’s portfolio: Life has an extensive offering of consumables for genomics, and molecular and cell biology. It is well-known for its next-generation sequencing capability, and also has a range of technologies for bioproduction and forensics applications. These strengths, combined with Thermo Fisher’s leading offerings in analytical technologies and specialty diagnostics, create new opportunities to support the convergence of life sciences tools and diagnostics.

• The merger creates enhances Thermo Fisher’s commercial strength and global reach: Life transacts more than half of its orders online through a highly regarded e-commerce platform. This leading capability, combined with Thermo Fisher’s extensive research and healthcare customer channels, creates a world-class commercial infrastructure. The combined company will also build on its strong foothold in Asia-Pacific, particularly in China, to meet increasing customer demand in life sciences and healthcare.

• The deal could create compelling value for shareholders, with attractive financial returns and new growth opportunities, Thermo fisher believes: The acquisition of Life presents the opportunity for $275 million of adjusted operating income synergies in year three following the close, consisting of $250 million of cost synergies and $25 million of revenue synergies. In addition, Thermo Fisher expects the transaction to be significantly and immediately accretive to adjusted EPS

(ID:39190880)